To our knowledge, no one study investigated the influence of p53 intron 3 and 6 polymorphisms on SCCHN survival, while a poor disease-free survival has been reported in patients carrying the p53 exon4 Arg72Pro variant on SCCHN, lung, colorectal and breast cancer [28-31]. This evidence concerns the gene TP53 and breast cancer.